Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Chinese PLA General Hospital
Cairo University
Augusta University
Washington University School of Medicine
Novartis
Taian Cancer Hospital
Karolinska Institutet
AstraZeneca
Medical College of Wisconsin
Brigham and Women's Hospital